Irv Loh, M.D.

Chief Medical Officer and Co-Founder

INFERMEDICA

Irv Loh, M.D.

Irv Loh MD did his undergraduate studies at UC Berkeley where he was elected PBK as a junior(top 0.5% of his class), earned his MD at UC San Francisco, elected AOA (medical honor society also as a third year medical student), and did his internal medicine residency at UCSF. He was trained in clinical research at the National Heart Lung & Blood Institute of the National Institutes of Health (NIH) in both the intramural and extramural divisions. He completed his cardiology fellowship at Cedars-Sinai in Los Angeles and joined their faculty in both the Department of Cardiology and Department of Thoracic and Cardiovascular Surgery. He later entered private practice in the disease management of cardiovascular diseases, focused on preventive cardiology and clinical research, founded the Ventura Heart Institute, and has been the principal investigator on over 160 phase 1, 2, and 3 clinical trials. He gave a TEDx lecture on the rationale of randomized, double-blinded, placebo controlled clinical trials. He is former Asst Prof of Medicine UCLA, current Adjunct Lecturer at Stanford University School of Medicine. He was a member of two Briefing Teams for President Clinton’s efforts on healthcare reform and was a White House Surrogate Speaker. When political and commercial interests defeated healthcare reform, he determined that technology would be a strategy to improve healthcare and began to consult and advise startups in Silicon Valley and elsewhere. He was the cardiology consultant on Doximity’s original medical advisory board. He is Chief Medical Officer and Co-Founder of Infermedica, an AI in healthcare company deployed in 30 countries and operating in 19 languages. He is a member of two WHO working groups on AI in symptom assessment and AI in clinical effectiveness. He is former chair of the Technology and Innovation Committee of the California Chapter of the American College of Cardiology where he organized and moderated an innovative technology colloquium for which he was awarded the CA ACC Outstanding Achievement Award. He advises startups on telemedicine, devices, and AI and is most passionate about the role of novel technologies in improving quality and efficiency of healthcare and as an experienced clinician how to optimally position themselves in the complex medical market.